Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent® HFA 110 mcg
Clinical trial NCT03879837 · COMPLETED
Trial details
- NCT number
- NCT03879837
- Sponsor
- Actavis Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-25
- Primary completion
- 2021-05-28
- Enrollment
- 1902
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.